Author details

Full Name

Rossella E Nappi

Affiliation

ORCID

Career Start Year

1991

Papers

325

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
36722687	Validation of a clinical tool for vestibular trophism in postmenopausal women.		2023
36306669	Prevalence and quality-of-life burden of vasomotor symptoms associated with menopause: A European cross-sectional survey.		2023
35430926	Pharmacotherapy for female sexual dysfunctions (FSDs): what is on the market and where is this field heading?	Expert Opinion on Pharmacotherapy	2023
37748960	Sexual health and contraception in the menopause journey.		2023
37582396	Using advanced analytics to help identify women who are more likely to have a severe subjective experience of vulvovaginal atrophy: a modeling study.		2023
37576184	Genitourinary Syndrome of Menopause in Breast Cancer Survivors: Current Perspectives on the Role of Laser Therapy.		2023
37634295	Impact of climate and environmental change on the menopause.		2023
37477342	What is in a name? A decade after changing from VVA to GSM have we come any closer to ending the 'silent suffering' of postmenopausal women with genitourinary symptoms?		2023
37084589	Oral estradiol/micronized progesterone may be associated with lower risk of venous thromboembolism compared with conjugated equine estrogens/medroxyprogesterone acetate in real-world practice.		2023
36897180	Safety of Fezolinetant for Vasomotor Symptoms Associated With Menopause: A Randomized Controlled Trial.		2023
37204690	Low prolactin level identifies hypoactive sexual desire disorder women with a reduced inhibition profile.		2023
37141915	Attitudes of women and pharmacists on the opportunity to obtain a progestogen-only pill over the counter - Italian outcomes.		2023
37017751	Expert opinion on the treatment of vulvovaginal atrophy with ospemifene based on new evidence.		2023
37199597	No-daily hormonal contraception today: general overview and application in specific clinical settings.		2023
37318030	Different local estrogen therapies for a tailored approach to GSM.		2023
36941212	Premenstrual dysphoric disorder and sexual function: a narrative review.		2023
37241304	Human Ovarian Follicular Fluid Mesenchymal Stem Cells Express Osteogenic Markers When Cultured on Bioglass 58S-Coated Titanium Scaffolds.		2023
36735200	Sexual functioning in women with functional hypothalamic amenorrhea: exploring the relevance of an underlying polycystic ovary syndrome (PCOS)-phenotype.		2023
36734148	Efficacy and Safety of Fezolinetant in Moderate to Severe Vasomotor Symptoms Associated With Menopause: A Phase 3 RCT.		2023
37038655	Is now the time to reconsider risks, benefits, and limitations of estrogen preparations as a treatment for menstrually related migraine?		2023
36918022	Women's attitudes about combined hormonal contraception (CHC) - induced menstrual bleeding changes - influence of personality traits in an Italian clinical sample.		2023
35241235	Men with COVID-19 die. Women survive.	Maturitas	2022
35525259	Menopause: a cardiometabolic transition.	Lancet Diabetes and Endocrinology,The	2022
35456034	Role of Estrogens in Menstrual Migraine.	Cells	2022
35574174	Recent advances in understanding/management of premenstrual dysphoric disorder/premenstrual syndrome.		2022
36011183	Hyaluronic Acid: A Valid Therapeutic Option for Early Management of Genitourinary Syndrome of Menopause in Cancer Survivors?	Healthcare (Switzerland)	2022
35745153	Crohn's Disease and Female Infertility: Can Nutrition Play a Supporting Role?	Nutrients	2022
35627968	Provoked Vestibulodynia and Topical Treatment: A New Option.	Healthcare (Switzerland)	2022
35428435	Medical Treatment of Female Sexual Dysfunction.	Urologic Clinics of North America	2022
36270315	The 2022 hormone therapy position statement of The North American Menopause Society: no news is good news.	Lancet Diabetes and Endocrinology,The	2022
35801642	Profile of Brazilian climacteric women: results from the Brazilian Menopause Study.	Climacteric	2022
36265322	Calprotectin as a novel diagnostic approach to screen male infertility risk: A pilot study.	Immunobiology	2022
36057183	Relationship between personality traits and sexual function in symptomatic postmenopausal women.		2022
36256517	The views of women and pharmacists on the desirability of a progestogen-only pill over the counter. Results of a survey in Germany, Italy and Spain.	European Journal of Contraception and Reproductive Health Care	2022
35723583	Polycystic ovary syndrome and sexuality.	Gynecological Endocrinology	2022
35352317	Biallelic mutations in PSMC3IP are associated with secondary amenorrhea: expanding the spectrum of prematureÂ ovarian insufficiency.	J Assist Reprod Genet	2022
35717261	More on age and gender in COVID-19.	Maturitas	2022
36591103	Digital integrated dramatherapy: A feasibility study in women undergoing assisted reproductive technology.		2022
36553061	Pathologic Findings at Risk Reducing Surgery in and Non- Mutation Carriers: A Single-Center Experience.		2022
34096694	Treatment of vulvo-vaginal atrophy with hyaluronate-based gel: a randomized controlled study.	Minerva Obstetrics and Gynecology	2022
33928470	Clinical features of migraine with onset prior to or during start of combined hormonal contraception: a prospective cohort study.	Acta Neurologica Belgica	2022
34860137	Missed opportunities in contraceptive counselling: findings from a European survey-based study with simulated patient consultation.	European Journal of Contraception and Reproductive Health Care	2022
35204953	Perimenstrual Asthma in Adolescents: A Shared Condition in Pediatric and Gynecological Endocrinology.	Children	2022
35107240	Menopause and female sexual dysfunctions.	Minerva Obstetrics and Gynecology	2022
34876374	Sexuality, pelvic floor/vaginal health and contraception at menopause.		2022
34477473	Efficacy and safety of prolonged-release hyaluronic acid derivative vaginal application in the postpartum period: a prospective randomised clinical trial.		2021
32369678	SARS-CoV-2, testosterone and frailty in males (PROTEGGIMI): A multidimensional research project.	Andrology	2021
33485472	Menopause transition: a golden age to prevent cardiovascular disease.	Lancet Diabetes and Endocrinology,The	2021
33703987	Prolactin as a neuroendocrine clue in sexual function of women across the reproductive life cycle: an expert point of view.	Gynecological Endocrinology	2021
33906204	A core outcome set for vasomotor symptoms associated with menopause: the COMMA (Core Outcomes in Menopause) global initiative.	Menopause	2021